AASLD 2026 5 - 9 November 2026

Semaglutide improves liver health in non‑obese participants with MASH: A post hoc analysis from the phase 3 ESSENCE trial

Authors :

Jörn M. Schattenberg¹; Matthew J. Armstrong²; Igor Bakulin³; Anja Geerts⁴; Jacob George⁵; Ewa Janczewska⁶; Niels Krarup⁷; Chun-Jen Liu⁸; Håvard Midgard⁹; Ahsan Shoeb⁷; Thea Vestergaard⁷; Michael Roden on behalf of the ESSENCE Study Group¹⁰